Mussi, C <br/><br/>
Post-imatinib surgery in advanced/metastatic GIST: is it worthwhile in all patients?  [electronic resource] 

 -  Annals of oncology : official journal of the European Society for Medical Oncology  Feb 2010 
 - 403-408 p.  digital 
<br/><br/> Publication Type: Evaluation Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1569-8041 
<br/><br/><label>Standard No.: </label>10.1093/annonc/mdp310  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--administration & dosage<br/>Benzamides<br/>Chemotherapy, Adjuvant<br/>Combined Modality Therapy<br/>Disease Progression<br/>Disease-Free Survival<br/>Drug Administration Schedule<br/>Female<br/>Follow-Up Studies<br/>Gastrointestinal Stromal Tumors--drug therapy<br/>Humans<br/>Imatinib Mesylate<br/>Male<br/>Medical Futility<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Piperazines--administration & dosage<br/>Pyrimidines--administration & dosage<br/>Retrospective Studies<br/>Treatment Outcome